Pfizer reportedly eyeing sale of hospital drugs unit

Pfizer (NYSE:PFE) has hired Goldman Sachs to gauge initial buyer interest as part of an attempt to sell its hospital drugs unit, Pfizer Hospital, potentially worth a few billion dollars, Reuters reported Tuesday, citing three people familiar with the